Using artificial intelligence technology to identify novel immunooncology targets

Using artificial intelligence technology to identify novel immuno-oncology targets

Researchers at Léon Bérard Cancer Center (CLB) will use artificial intelligence (AI) based bioanalysis and bioinformatics to identify novel targets in immuno-oncology. This research program will use different patient cohorts and tumour biopsies to...

More From BioPortfolio on "Using artificial intelligence technology to identify novel immuno-oncology targets"